{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/RHLD/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T09:01:37.114Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9954,"canonical_name":"Resolute Holdings Management, Inc.","cik":"0002039497","uei":null,"lei":null,"duns":null,"ticker":"RHLD"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":10},"count":10,"timeline":[{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — Resolute Holdings Management, Inc. — 2026-08-24","url_slug":"/sec/cik-0002039497/4/0001628280-26-058740","accession_number":"0001628280-26-058740","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Resolute Holdings Management, Inc. — 2026-08-06","url_slug":"/sec/cik-0002039497/schedule-13d-a/0000950142-26-002274","accession_number":"0000950142-26-002274","importance":70},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Resolute Holdings Management, Inc. — 2026-08-06","url_slug":"/sec/cik-0002039497/10-q/0001104659-26-091709","accession_number":"0001104659-26-091709","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Resolute Holdings Management, Inc. — 2026-08-06","url_slug":"/sec/cik-0002039497/8-k/0001104659-26-091621","accession_number":"0001104659-26-091621","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"SD","title":"SD — Resolute Holdings Management, Inc. — 2026-06-30","url_slug":"/sec/cik-0002039497/sd/0000950142-26-001923","accession_number":"0000950142-26-001923","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — James Mark R. — 2026-06-15","url_slug":"/sec/cik-0001417954/4/0000950142-26-001797","accession_number":"0000950142-26-001797","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — THOMPSON JANE J. — 2026-06-15","url_slug":"/sec/cik-0001551788/4/0000950142-26-001800","accession_number":"0000950142-26-001800","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — Resolute Holdings Management, Inc. — 2026-05-15","url_slug":"/sec/cik-0002039497/4/0001628280-26-035754","accession_number":"0001628280-26-035754","importance":30},{"ts":"2026-05-14","kind":"sec.insider.p","reporter":"Mikkilineni Krishna","title":null,"shares":921.396,"price_per_share":108.52,"usd_value":99990,"security_title":"Common Stock, par value $0.0001 per share","importance":50.09998989392},{"ts":"2026-05-13","kind":"sec.insider.p","reporter":"Schoen Kurt","title":"Chief Financial Officer","shares":450,"price_per_share":108.34,"usd_value":48753,"security_title":"Common Stock, par value $0.0001 per share","importance":50.048753}]}